As if InVivo Therapeutics (OTC:NVIV) wasn’t having a tough enough time already, the company’s stock is under even more pressure as former CEO Frank Reynolds has been liquidating his position over the last few weeks.
NVIV shares were down about 6% today to trade at 64¢ apiece as of about 1:55 p.m. EST. The stock has dropped more than 40% over the last 3 months and is down nearly 70% since the start of 2014.
Reynolds began selling tens of thousands of shares each month in January 2013 and continued to do so at a sprint until May this year (see below for all his reported NVIV trading activity).
Help employers find you! Check out all the jobs and post your resume.
